x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Nucleate Singapore Pulse

Nucleate Singapore

Singapore"s premier podcast on the biotech ecosystem. The show notes and transcripts can be found on nucleatesingapore.substack.com. Subscribe and follow us to keep your finger on the pulse of Singapore’s biotech ecosystem. For feedback and suggestions, feel free to reach out to the team at singapore@nucleate.org

science life sciences

All Episodes

00:40:10

Mining Bat Biology for Novel Therapeutic Strategies...

Nucleate Singapore Pulse ·

2025/12/18

Dr. Lewis Hong is the Vice President of Paratus Sciences, a biotech company uncovering novel therapeutics by studying the extreme biology of bats. With a background spanning genomics research, pigmentation genetics at Stanford, and leadership roles in translational sciences at MSD, Lewis brings deep scientific and industry expertise to this pioneering field. In this episode, Lewis shares how Paratus was founded to explore bats as a unique model for human health. He explains how the company built a

en

00:40:10

Simplifying medication regimens through 3D-printed...

Nucleate Singapore Pulse ·

2025/06/30

Dr. Goh Wei Jiang is the Co-founder and CEO of CraftHealth, a pioneering Singapore-based startup revolutionizing personalized medicine through 3D printing. With a background in pharmacy and a PhD-MBA from NUS, Dr. Goh brings both scientific expertise and commercial insight to the forefront of MedTech innovation. Drawing on his clinical experience and translational research, he co-founded CraftHealth to solve a real-world challenge: simplifying polypharmacy and improving drug compliance through

en

00:36:07

Redefining Bioconjugation and the Future of ADCs with...

Nucleate Singapore Pulse ·

2025/05/16

Dr. Abbas Sahili is the CTO of Singzyme, a biotechnology company pioneering next-generation bioconjugation technologies. With a strong background in biochemistry and structural biology, Abbas brings deep scientific expertise and entrepreneurial vision to the field of precision medicine. His transition from academia to biotech leadership is marked by a commitment to developing antibody-drug conjugates (ADCs) that are more efficient, effective, and accessible. Under his leadership, Singzyme has

en

00:39:31

Devising new methods of next-genetic testing with...

Nucleate Singapore Pulse ·

2025/04/29

Dr. Hoa Giang is the Co-founder and Data Science Lead of Gene Solutions. His background boasts a broad range of experience in the global therapeutics industry. His technical background includes computational biology, bioinformatics analysis and understanding genetic interactions and how they affect the cellular functions. This experience and immense knowledge inform his mindful and robust approach to founding Gene Solutions. Hoa’s experience spans the globe having lived, studied and worked in

en

00:22:36

Inspiring the next breakthroughs in cancer therapy...

Nucleate Singapore Pulse ·

2025/03/28

Dr. Ivan Horak is currently the CEO and founder of Tikva Allocell, a biotech company whose mission is to develop safe, effective, readily available and affordable “off-the-shelf” T cell therapies by leveraging excellent safety profile of proprietary technologies that enhance the T cell's performance to treat cancer.In this episode, Ivan shares his journey from having an interest in becoming a medical oncologist. He also shares how his experience in working in some of the top oncology institutes

en

00:34:42

Redirecting Immunity to fight Cancer with VerImmune's...

Nucleate Singapore Pulse ·

2025/02/16

Dr. Joshua Wang is currently the CEO and founder of VerImmune, a biotech company focused on developing novel virus inspired particle technology platform that can be used as a delivery system to target cancers.In this episode, Josh shares his journey from having an interest in infectious diseases to leading a biotech startup that spans across the US and Singapore. VerImmune specializes in developing Virus-Inspired Particle (VIP) technology for targeting cancers. Josh discusses his academic

en

00:40:40

Strategizing for fundraising success with...

Nucleate Singapore Pulse ·

2024/12/20

Ritika Khetawat is the founder of MissionBridge, a fundraising advisory firm that empowers Singapore’s biotech and medtech ventures to secure the capital they need. In this episode, Ritika discusses her transition from investment banking at Goldman Sachs and Morgan Stanley to supporting healthcare startups through MissionBridge. She shares her insights into the unique challenges of biotech fundraising, emphasizing the need for strategic planning, strong storytelling, and relationship-building with

en

00:25:26

Innovating new cancer-selective biologics with PairX...

Nucleate Singapore Pulse ·

2024/11/16

Dr David M. Epstein is the co-founder and president of PairX Bio, a company that specializes in the next generation of cancer selective biologics.In this episode, David shares his experience and journey from working in various biotech companies and big pharma institutions to eventually building his own companies. One of these is Pairx Bio, a company specializing in the next generation of cancer biologics. David stresses the importance of how being able to follow the science and being transparent

en

00:36:31

Empowering biotech startups with JLABS Singapore’s...

Nucleate Singapore Pulse ·

2024/10/16

Dr. Alessandro Falcone is the Head of JLABS Singapore. In this episode, Alessandro talks about his transition from clinical medicine to business consulting, eventually landing in leadership roles at major pharmaceutical companies. He explains the mission of JLABS Singapore, a collaboration between Johnson & Johnson and Singapore’s Economic Development Board, which aims to nurture early-stage biotech and medtech startups. Alessandro highlights JLABS’ shift from a traditional lab incubator to a

en

00:49:06

Simulating atomic movement with QDX's Loong Wang

Nucleate Singapore Pulse ·

2024/09/15

Loong Wang is the CEO and Co-Founder of QDX, a company specializing in computational drug discovery using quantum mechanics and supercomputing. In this episode, Loong discusses his journey from supercomputing at the Australian National University to founding multiple startups in distributed computing and blockchain—before making a significant pivot to biotechnology. His deep dive into quantum chemistry aims to address complex drug discovery challenges by simulating atomic and molecular behaviors at

en

00:35:37

Fermenting sustainable foodtech with TurtleTree’s...

Nucleate Singapore Pulse ·

2024/08/15

Fengru Lin is the Founder and CEO of TurtleTree, a pioneering biotechnology company that has successfully developed the world’s first sustainably produced lactoferrin “LF+” using precision fermentation technology.In this episode, Fengru Lin shares her journey from a tech career at Google and Salesforce to leading biotech innovations at TurtleTree. Inspired by challenges in replicating traditional cheese-making in Asia, she envisioned revolutionizing the dairy industry. Fengru discusses TurtleTree’s

en

00:35:03

Harnessing the power of antibody therapeutics with...

Nucleate Singapore Pulse ·

2024/07/15

Dr. Lisa Ooi is the Senior Vice President of Strategy at Hummingbird Bioscience, a leading biotech company in Singapore focused on antibody therapeutics. In this episode, Dr. Ooi discusses her journey from her PhD at Stanford to her current role, highlighting her experience in biomedical research and corporate strategy. She delves into Hummingbird Bioscience's innovative platform for developing antibody-based therapies, sharing insights on the company's strategic direction, the challenges of

en

00:43:24

Protecting innovations in biotech with Mewburn Ellis’...

Nucleate Singapore Pulse ·

2024/06/15

Dr. Adam Gregory is a Partner and Patent Attorney at Mewburn Ellis LLP. He works with biotech companies to build and manage their patent portfolios, drafting patent applications and co-ordinating prosecution worldwide. In this episode, he highlights success stories from Singapore’s vibrant biotech scene, including Enleofen Bio and Hummingbird Bioscience, and discusses the evolving nature of patent strategies in the face of emerging technologies like AI and gene editing. From understanding the

en

00:43:36

Finding a cure for hematologic malignancies with Vor...

Nucleate Singapore Pulse ·

2024/05/15

Dr. Robert Ang is the CEO of Vor Bio, a clinical-stage cell and genome engineering therapy company. In this episode, Dr. Ang discusses the challenges of treating cancer, particularly acute myeloid leukemia (AML), and the need for new and innovative approaches. The conversation delves into the challenges of navigating clinical trials during the pandemic and securing funding for research and development. Lastly, he explains how Vor Bio is using cell and gene therapies, such as CAR-T cells and genome

en

00:29:18

Advancing Singapore's biotech ecosystem with Albatroz...

Nucleate Singapore Pulse ·

2024/04/22

Dr. Guy Heathers is the Chief Business Officer and one of the co-founders of Albatroz Therapeutics. In this episode, Dr. Guy Heathers shares his insights and experiences in the biotech industry, focusing on the challenges and opportunities faced by startups in Singapore. He discusses the importance of patent protection, the need for strong product development capabilities, and the significance of effective interaction with pharma companies. Dr. Heathers emphasizes the value of pursuing

en

00:34:42

Advancing Singapore's biotech ecosystem with Albatroz...

Nucleate Singapore Pulse ·

2024/04/14

Dr. Guy Heathers is the Chief Business Officer and one of the co-founders of Albatroz Therapeutics, a preclinical stage biotech company focused on developing therapeutic antibodies and antibody drug conjugates for the treatment of solid tumors and arthritis. In this episode, Dr. Guy Heathers shares his extensive experience in the biotech industry and discusses the challenges and opportunities in Singapore's biotech ecosystem. He talks about how he became involved in building the biotech industry

en

00:28:56

Screening diseases through pharmacogenomics with...

Nucleate Singapore Pulse ·

2024/03/15

Levana Sani is the co-founder and CEO of NalaGenetics. In this episode, Levana shares how her background in biochemistry and her MBA from Harvard Business School helped shape her understanding of the business side of science. She explains the four main problems NalaGenetics aims to solve in the field of genetic testing and the challenges they faced in the early stages. Additionally, she highlights the differences in commercialisation in Singapore and Indonesia, and the current challenges faced with

en

00:35:39

Modeling human skin in 4D with REVIVO BioSystems’ Dr....

Nucleate Singapore Pulse ·

2024/02/15

Dr. Massimo Alberti is the CEO and co-founder of REVIVO BioSystems. In this episode, Dr. Alberti shares valuable insights into the process of spinning off a technology from an academic setting. He discusses the genesis of REVIVO BioSystems, the development of their innovative 4D human tissue models, and the pivotal role of perseverance, interdisciplinary collaboration, and client feedback in shaping REVIVO BioSystems' trajectory. Aspiring biomedical entrepreneurs and young scientists will find

en

00:36:39

Investing in biotech with TPG Life Sciences...

Nucleate Singapore Pulse ·

2024/01/15

Dr. Carolyn Ng is the Managing Director and Partner of TPG Life Sciences Innovations. With a decade of expertise in life sciences investment under her belt, she's the powerhouse behind infusing capital into groundbreaking startup companies in precision oncology, immunology, ophthalmology, metabolic diseases, and rare diseases.In this episode, Dr. Carolyn Ng shares her journey from academia to venture capital and discusses the investment thesis of her company. She also shares her insights on

en

00:21:37

Diagnosing GI diseases using AI with Iterative...

Nucleate Singapore Pulse ·

2023/12/15

Dr. Jonathan Ng is the CEO and founder of Iterative Health, a company that focuses on AI diagnostics for gastrointestinal diseases. In this episode, Dr. Jonathan Ng discusses his journey from medical school to entrepreneurship and the development of AI diagnostics for gastrointestinal diseases. He shares his experiences in healthcare and the challenges he faced in starting a company focused on AI. He also talks about the importance of mentorship and the role of AI in transforming healthcare. He

en

24 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter